The in vitro effects of new D186 dendrimer on virulence factors of Candida albicans

Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility

(2013) Rathi Saravanan et al.   BIOTECHNOLOGY AND BIOENGINEERING

Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity

(2013) Alessia Bertini et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Novel Antimicrobial Peptide Dendrimers with Amphiphilic Surface and Their Interactions with Phospholipids — Insights from Mass Spectrometry

(2013) Piotr Polcyn et al.   MOLECULES

Candida albicanspathogenicity mechanisms

(2013) François L. Mayer et al.   Virulence

Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans

(2012) Cosimo D. Cadicamo et al.   BIOCHEMICAL PHARMACOLOGY

Bicyclic peptidomimetics targeting secreted aspartic protease 2 (SAP2) from Candida albicans reveal a constrained inhibitory chemotype

(2012) Chiara Calugi et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009

(2012) P. Zarb et al.   CLINICAL MICROBIOLOGY AND INFECTION

RNA-Mediated Gene Silencing in Candida albicans: Inhibition of Hyphae Formation by Use of RNAi Technology

(2012) Maryam Moazeni et al.   MYCOPATHOLOGIA

Secreted Aspartic Protease Cleavage of Candida albicans Msb2 Activates Cek1 MAPK Signaling Affecting Biofilm Formation and Oropharyngeal Candidiasis

(2012) Sumant Puri et al.   PLoS One

Endocytosis-Mediated Vacuolar Accumulation of the Human ApoE Apolipoprotein-Derived ApoEdpL-W Antimicrobial Peptide Contributes to Its Antifungal Activity in Candida albicans

(2011) Tristan Rossignol et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis

(2011) L. A. Braga-Silva et al.   CURRENT MEDICINAL CHEMISTRY

Transcription Factor Efg1 Shows a Haploinsufficiency Phenotype in Modulating the Cell Wall Architecture and Immunogenicity of Candida albicans

(2011) Martin Zavrel et al.   EUKARYOTIC CELL

Host–pathogen interactions and virulence-associated genes during Candida albicans oral infections

(2011) Ronny Martin et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Candida albicans interactions with epithelial cells and mucosal immunity

(2011) Julian R. Naglik et al.   MICROBES AND INFECTION

Membranolytic antifungal activity of arenicin-1 requires the N-terminal tryptophan and the beta-turn arginine

(2010) Cana Park et al.   BIOTECHNOLOGY LETTERS

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases

(2010) L.A. Braga-Silva et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Proteolytic Cleavage of Covalently Linked Cell Wall Proteins by Candida albicans Sap9 and Sap10

(2010) Lydia Schild et al.   EUKARYOTIC CELL

Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents

(2010) Bo Fang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

General factors important for the formation of structured biofilm-like yeast colonies

(2010) Vratislav Št’ovíček et al.   FUNGAL GENETICS AND BIOLOGY

Limited Role of Secreted Aspartyl Proteinases Sap1 to Sap6 in Candida albicans Virulence and Host Immune Response in Murine Hematogenously Disseminated Candidiasis

(2010) A. Correia et al.   INFECTION AND IMMUNITY

The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin derivatives with promising pharmaceutical potential

(2010) Aaron P. Podorieszach et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

New small-size peptides possessing antifungal activity

(2009) Francisco M. Garibotto et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Cellular interactions ofCandida albicanswith human oral epithelial cells and enterocytes

(2009) Frederic Dalle et al.   CELLULAR MICROBIOLOGY

Multiple effects of amprenavir againstCandida albicans

(2009) Lys A. Braga-Silva et al.   FEMS YEAST RESEARCH

Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis

(2008) Julian R. Naglik et al.   MICROBIOLOGY-SGM

Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans

(2008) Ulrich Lermann et al.   MICROBIOLOGY-SGM

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

(2007) Z. A. Kanafani et al.   CLINICAL INFECTIOUS DISEASES